Neuroprotective role of erythropoietin in neonates

Abstract

This review summarizes target populations of neonates for which erythropoietin (Epo) neuroprotective therapy might be of benefit, and the mechanisms by which Epo functions as a neuroprotective agent. Potential risks of Epo are reviewed. Finally, the progression of Epo neuroprotection from preclinical studies to translational studies is discussed.

Keywords::

• Erythropoietin
• neuroprotection, neonates

Declaration of Interest: The author reports no conflicts of interest.